NAMI
TARS icon

Nomura Asset Management International’s Tarsus Pharmaceuticals TARS Stock Holding History

Nomura Asset Management International’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.2M Buy
607,272
+107,419
+21% +$6.86M 0.06% 432
2026
Q1 		$35.1M Sell
499,853
-84,833
-15% -$5.93M 0.06% 416
2025
Q4 		$47.9M Buy
+584,686
New +$43.7M 0.07% 371

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nomura Asset Management International's TARS Position: Q2 2026 in Review

Nomura Asset Management International increased its Tarsus Pharmaceuticals (TARS) stake by 21% in Q2 2026, buying an estimated $6.86M and bringing the position to 607,272 shares worth $38.2M. The position accounts for 0.06% of the portfolio, ranked #432.

Nomura Asset Management International first reported a position in TARS in Q4 2025 and has held it in 3 quarters since. The position peaked at $47.9M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Nomura Asset Management International held 607,272 shares of Tarsus Pharmaceuticals worth $38.2M as of Q2 2026.
  • Nomura Asset Management International bought 107,419 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $6.86M.
  • Tarsus Pharmaceuticals made up 0.06% of Nomura Asset Management International's portfolio in Q2 2026, its #432 holding.
  • Nomura Asset Management International first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's Tarsus Pharmaceuticals position peaked at $47.9M in Q4 2025.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.